IL65137A - (hetero)aroylimidazolones and pharmaceutical compositions containing them - Google Patents

(hetero)aroylimidazolones and pharmaceutical compositions containing them

Info

Publication number
IL65137A
IL65137A IL65137A IL6513782A IL65137A IL 65137 A IL65137 A IL 65137A IL 65137 A IL65137 A IL 65137A IL 6513782 A IL6513782 A IL 6513782A IL 65137 A IL65137 A IL 65137A
Authority
IL
Israel
Prior art keywords
aroylimidazolones
hetero
pharmaceutical compositions
compositions containing
aroylimidazole
Prior art date
Application number
IL65137A
Other languages
English (en)
Other versions
IL65137A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL65137A0 publication Critical patent/IL65137A0/xx
Publication of IL65137A publication Critical patent/IL65137A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL65137A 1981-03-05 1982-03-01 (hetero)aroylimidazolones and pharmaceutical compositions containing them IL65137A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use

Publications (2)

Publication Number Publication Date
IL65137A0 IL65137A0 (en) 1982-05-31
IL65137A true IL65137A (en) 1987-02-27

Family

ID=26933806

Family Applications (1)

Application Number Title Priority Date Filing Date
IL65137A IL65137A (en) 1981-03-05 1982-03-01 (hetero)aroylimidazolones and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US4405628A (enExample)
EP (1) EP0059948B1 (enExample)
KR (1) KR890000765B1 (enExample)
AT (1) ATE16489T1 (enExample)
AU (1) AU557590B2 (enExample)
CA (1) CA1190550A (enExample)
DE (1) DE3267352D1 (enExample)
DK (1) DK168627B1 (enExample)
ES (2) ES510087A0 (enExample)
GB (1) GB2096600B (enExample)
GR (1) GR76518B (enExample)
HK (1) HK61686A (enExample)
IE (1) IE52387B1 (enExample)
IL (1) IL65137A (enExample)
MY (1) MY8600700A (enExample)
NO (1) NO157175C (enExample)
NZ (1) NZ199885A (enExample)
PH (1) PH18345A (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
CA1262732C (en) * 1984-07-30 1989-11-07 PREPARATION OF 1,3-DIHYDRO-4-PYRIDOYL-2H-IMIDAZOL-2-ONES
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
WO1992000282A1 (en) * 1990-06-29 1992-01-09 The Upjohn Company Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
HK1218629A1 (zh) 2013-02-25 2017-03-03 Bausch Health Ireland Limited 用於结肠清洁的鸟苷酸环化酶受体激动剂
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014197720A2 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
US20160184387A1 (en) 2013-08-09 2016-06-30 Dominique Charmot Compounds and methods for inhibiting phosphate transport
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
GB2096600B (en) 1985-06-05
NZ199885A (en) 1985-04-30
ES8402827A1 (es) 1984-03-01
GB2096600A (en) 1982-10-20
DK95482A (da) 1982-09-06
AU557590B2 (en) 1986-12-24
US4405628A (en) 1983-09-20
DK168627B1 (da) 1994-05-09
AU8103782A (en) 1982-09-09
EP0059948A1 (en) 1982-09-15
DE3267352D1 (en) 1985-12-19
IE820491L (en) 1982-09-05
PH18345A (en) 1985-06-05
NO157175B (no) 1987-10-26
EP0059948B1 (en) 1985-11-13
ATE16489T1 (de) 1985-11-15
HK61686A (en) 1986-08-29
IE52387B1 (en) 1987-10-14
NO820686L (no) 1982-09-06
NO157175C (no) 1988-02-03
KR890000765B1 (ko) 1989-04-05
GR76518B (enExample) 1984-08-10
ES8305352A1 (es) 1983-04-16
ES519254A0 (es) 1984-03-01
IL65137A0 (en) 1982-05-31
CA1190550A (en) 1985-07-16
MY8600700A (en) 1986-12-31
KR830009046A (ko) 1983-12-17
ES510087A0 (es) 1983-04-16

Similar Documents

Publication Publication Date Title
IL65137A (en) (hetero)aroylimidazolones and pharmaceutical compositions containing them
IE842979L (en) Desulfatohirudins
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
IL66256A0 (en) Water containing compositions comprising salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
IL58775A (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
DE3378580D1 (en) Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them
IL62198A0 (en) 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them
JPS57122085A (en) Circulatory disease extirpenter and use
ZA859382B (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
JO1406B1 (en) Chemical compounds
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
NZ218238A (en) Thiazolone derivatives and pharmaceutical compositions
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
GR69267B (enExample)
IL61989A0 (en) Phenyl piperazine derivatives of 1,3,4-oxadiazolylphenols,their preparation and pharmaceutical compositions containing them
IL66028A0 (en) Saturated aminocyclitol derivatives,their preparation and pharmaceutical compositions containing them
JPS56167636A (en) Use of 4-phenyl-4-oxy-2-hydroxybutanoic acid substitution derivative as drug

Legal Events

Date Code Title Description
KB Patent renewed
EXP Patent expired
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.